BIP

Legal form

Joint-stock company
KRS: 0000154178 District Court for the Capital City of Warsaw in Warsaw, 12th Commercial Division of the National Court Register (KRS)
NIP: 525-00-04-220
Regon: 000288343 

Contact details
Registered office: ul. Jana Kazimierza 16 01-248 Warsaw Registered office: ul. Jana Kazimierza 16 01-248 Warsaw Correspondence address: Centrala Farmaceutyczna CEFARM SA ul. Jana Kazimierza 16 01-248 Warsaw
e-mail: cefarm@cefarm.com.pl; www.cefarm.com.p
T: (+48 22) 634-02-22 (head office) F: (+48 22) 634-03-59

Company bodies

1.  Management Board

Jan Kruk – President of the Management Board

2.  Supervisory Board
Katarzyna Blachowicz – Chair of the Supervisory Board
Anna Miszczak – Deputy Chair of the Supervisory Board
Wojciech Plopa – Member of the Supervisory Board
Magdalena Murawska - Member of the Supervisory Board
Paweł Leszek Syga - Member of the Supervisory Board
3.  General Meeting – the Minister of the Treasury


Organisation
Pursuant to the Permit issued by the Chief Pharmaceutical Inspector (no. GIF-P-Z-4301734/93/94/TP/03/RB/05) on 24.11.2005, CF CEFARM SA operates a pharmaceutical wholesaler located in Warsaw at 16 Jana Kazimierza Street, which also has reloading chambers located in Łódź at 230 Kilińskiego Street and in Radomsko at 65 I.Krasickiego Street.

Additionally, on the basis of relevant permits, the Company's facilities also accommodate consignment warehouses and a bonded warehouse.

The Company's business activity
Wholesale and retail of medicinal products and medical and other devices, transport, storage and warehousing of goods, market and public opinion research, consulting, advertising. Ownership structure and equity. Share capital as at 31.12.2014 amounts to PLN 55,400,000.00 and includes 5.54 million shares with a unit value of PLN 10.00. All shares are taken up by the State Treasury. The capital is paid up in 100%.

The Company’s assets
Net asset value as at 31.12.2018 – PLN 325,868,988.61

The Company’s income
Net revenues from sales for financial year 2018 – PLN 1,168,900,701.54